5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with natriuretic peptide, brain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Book, M; Hahn, M; Luedi, MM; Rieder, HU; Stamer, UM; Stüber, F | 1 |
Chai, D; Hu, J; Liang, M; Lin, C; Lin, S; Liu, W; Qiu, J; Wu, X; Xu, H; Yu, J; Zeng, K; Zhang, N | 1 |
2 other study(ies) available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and natriuretic peptide, brain
Article | Year |
---|---|
ASA Status,
Topics: Atrial Natriuretic Factor; Coronary Artery Disease; Haplotypes; Humans; Natriuretic Peptide, Brain; Natriuretic Peptides; Nitrobenzoates; Peptide Fragments; Procainamide | 2022 |
The underlying mechanism of transcription factor IRF1, PRDM1, and ZNF263 involved in the regulation of NPPB rs3753581 on pulse pressure hypertension.
Topics: Blood Pressure; DNA-Binding Proteins; Genotype; Humans; Hypertension; Interferon Regulatory Factor-1; Natriuretic Peptide, Brain; Peptide Fragments; Positive Regulatory Domain I-Binding Factor 1; Transcription Factors | 2023 |